AGP Picks
View all

Synchronyx wins Digital Health & AI Rising Star Award for medication adherence platform

5 hours ago
Synchronyx wins Digital Health & AI Rising Star Award for medication adherence platform
By AI, Created 21:43 UTC, Nov 19, 2026, AGP -

Synchronyx won a 2026 Rising Star Award at the Digital Health & AI Awards in Las Vegas for its patient engagement platform Tappt and linked discharge tool Linkt. The recognition highlights software aimed at improving treatment persistence, patient retention and care transitions for health systems, pharmacies and life sciences companies.

Why it matters: - Synchronyx is targeting a common gap in care: what happens after a prescription is written or a patient leaves the hospital. - The company’s tools aim to surface medication issues, symptoms and access barriers before patients disengage from treatment. - Health systems, pharmacies and life sciences teams can use that data to focus support where it is most needed.

What happened: - Synchronyx won a Rising Star award in the Therapeutics, Pharmacy & Medication Innovation category at the 2026 Digital Health Hub – Digital Health & AI Awards. - The Digital Health Hub Foundation announced the awards on Nov. 16 at HLTH USA in Las Vegas. - The award follows Tappt Health being named a finalist in the Digital Health Solutions category of the 2026 Fierce Life Sciences Innovation Awards.

The details: - Tappt turns the medication package into a connected care experience. - Patients can tap a battery-free smart label to access guidance, medication tracking and a way to share concerns with their care team. - The experience does not require an app download. - Care teams can see patient-reported medication use, symptoms and barriers in near real time. - Synchronyx says the visibility helps teams identify who needs help and coordinate follow-up. - The company works with more than 40 health system and pharmacy partners. - Synchronyx also works with life sciences organizations on patient support, research and quality improvement programs. - The company’s applications cover oral, injectable and infusion therapies, plus care transitions.

Between the lines: - The award signals growing interest in tools that extend patient support beyond the clinic or pharmacy counter. - Synchronyx is positioning its platform as both a care-delivery tool and a data source for research and quality improvement. - The company’s emphasis on patient-reported outcomes and real-world data also fits broader interest in evidence generation for digital health. - Its mention of prescription drug use-related software, or PDURS, suggests the platform may be relevant to regulated digital therapy companion programs when used with the right evidence and intended-use framework.

What's next: - Health systems and pharmacies can use Tappt for remote therapeutic monitoring and between-visit engagement. - Specialty pharmacies can use the platform to identify missed-dose drivers such as tolerability concerns, refill delays and access problems. - Hospital discharge programs can use Linkt to keep patients connected after they return home. - Life sciences teams can use configurable digital companions to support education, check-ins and care-team communication where clinically appropriate. - Organizations interested in medication adherence, digital companion or discharge support programs can request a discussion at more information. - Research and publications are available at the evidence page.

The bottom line: - Synchronyx is betting that better post-prescription and post-discharge communication can improve persistence, retention and continuity of care.

Disclaimer: This article was produced by AGP Wire with the assistance of artificial intelligence based on original source content and has been refined to improve clarity, structure, and readability. This content is provided on an “as is” basis. While care has been taken in its preparation, it may contain inaccuracies or omissions, and readers should consult the original source and independently verify key information where appropriate. This content is for informational purposes only and does not constitute legal, financial, investment, or other professional advice.

Sign up for:

Global Education Journal

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Global Education Journal

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.